Entrada Therapeutics, Inc.

TRDA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$6.75-2.17%

2026-09-18

Financials

Valuation Metrics

Entrada Therapeutics, Inc.'s Market Cap is $262M. At end of 2025 it was $425M. Ranked #2974 of 3,121 in US market (top 95%), #1348 of 1,463 on NASDAQ (top 92%), #246 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 92%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$262M	US#2,974/3,121 Sec#246/266
Revenue	$5M	US#2,853/3,121 Sec#180/266
Net Income	$-166M	US—/3,121 Sec—/266
Total Assets	$299M	US#2,916/3,121 Sec#209/266
Net Assets	$233M	US#2,631/3,121 Sec#177/266
Value
P/B	1.12x	US#531/3,121 Sec#17/266
P/S	55.92x	US#2,924/3,121 Sec#166/266
FCF Yield	-51.27%	US—/3,121 Sec—/266
Profitability
ROE	-71.02%	US#2,755/3,121 Sec#188/266
ROA	-55.47%	US#3,006/3,121 Sec#223/266
Op. Margin	-3767.07%	US#2,853/3,121 Sec#176/266
Revenue Growth	-94.10%	US#2,771/3,121 Sec#184/266
Financial Health
Debt Ratio	28.05%	US#308/3,121 Sec#98/266
Total Debt	$49M	US#2,620/3,121 Sec#154/266
FCF	$-134M	US#2,697/3,121 Sec#166/266
Cash	$99M	US#2,233/3,121 Sec#176/266
Current Ratio	10.89x	US#233/3,121 Sec#72/266
Performance
1Y Return	21.62%	US#793/3,121 Sec#128/266
1M Return	-13.24%	US#1,723/3,121 Sec#141/266
From 52W High	-58.97%	US#2,888/3,121 Sec#233/266
1Y MDD	-64.75%	US#2,878/3,121 Sec#227/266
Trading
Volume	286,124 shares	US#2,489/3,121 Sec#241/266
Trading Value	$2M	US#2,926/3,121 Sec#248/266
Per Share
EPS	$-4.27	US—/3,121 Sec—/266
BPS	$6.01	US#2,193/3,121 Sec#111/266